Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171

Ventromedial Prefrontal Cortex Is Critical for the Regulation of Amygdala Activity in Humans

(2015) Julian C. Motzkin et al.   BIOLOGICAL PSYCHIATRY

Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point to a chronic stress hypothesis

(2015) Gwendolyn C. Dieleman et al.   PSYCHONEUROENDOCRINOLOGY

Neuroimaging in social anxiety disorder—A meta-analytic review resulting in a new neurofunctional model

(2014) Annette Beatrix Brühl et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Effects of substance P and Sar-Met-SP, a NK1 agonist, in distinct amygdaloid nuclei on anxiety-like behavior in rats

(2014) Gabriel Shimizu Bassi et al.   NEUROSCIENCE LETTERS

The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study

(2014) Laura E. Kwako et al.   PSYCHOPHARMACOLOGY

Tacr1 Gene Variation and Neurokinin 1 Receptor Expression Is Associated with Antagonist Efficacy in Genetically Selected Alcohol-Preferring Rats

(2013) Jesse R. Schank et al.   BIOLOGICAL PSYCHIATRY

Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour

(2013) Alessio Squassina et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

In Search of the Trauma Memory: A Meta-Analysis of Functional Neuroimaging Studies of Symptom Provocation in Posttraumatic Stress Disorder (PTSD)

(2013) Gudrun Sartory et al.   PLoS One

Meta-analysis of functional brain imaging in specific phobia

(2013) Jonathan C. Ipser et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Corticolimbic Brain Reactivity to Social Signals of Threat Before and After Sertraline Treatment in Generalized Social Phobia

(2012) K. Luan Phan et al.   BIOLOGICAL PSYCHIATRY

Neuroimaging of Serotonin System in Anxiety Disorders

(2012) Eduard Maron et al.   CURRENT PHARMACEUTICAL DESIGN

Age, sex and NK1 receptors in the human brain — A positron emission tomography study with [11C]GR205171

(2012) Jonas Engman et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Gender-specific abnormalities in the serotonin transporter system in panic disorder

(2012) Dara M. Cannon et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A pharmacokinetic PET study of NK1 receptor occupancy

(2011) Stefano Zamuner et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

(2011) Emiliangelo Ratti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial

(2010) Sanjay J. Mathew et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Gender differences in brain serotonin transporter availability in panic disorder

(2010) Eduard Maron et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder

(2010) Izelle Labuschagne et al.   NEUROPSYCHOPHARMACOLOGY

Short-term NK1 receptor antagonism and emotional processing in healthy volunteers

(2010) Abbie Pringle et al.   PSYCHOPHARMACOLOGY

Emotional processing in anterior cingulate and medial prefrontal cortex

(2010) Amit Etkin et al.   TRENDS IN COGNITIVE SCIENCES

Substance P in Stress and Anxiety

(2009) Karl Ebner et al.   Annals of the New York Academy of Sciences

Decreased Neurokinin-1 (Substance P) Receptor Binding in Patients with Panic Disorder: Positron Emission Tomographic Study with [18F]SPA-RQ

(2009) Yota Fujimura et al.   BIOLOGICAL PSYCHIATRY

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

(2009) Johannes Tauscher et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers

(2009) Ciara McCabe et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Neurocircuitry of Fear, Stress and Anxiety Disorders

(2009) Lisa M Shin et al.   NEUROPSYCHOPHARMACOLOGY

Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics

(2008) Sanjay J. Mathew et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS

Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429

(2008) Nicolas Singewald et al.   JOURNAL OF NEUROCHEMISTRY

Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication-Naive Patients with Generalized Social Anxiety Disorder Shown by 123I- -(4-Iodophenyl)-Tropane SPECT

(2008) N. J. van der Wee et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of Substance P in the Amygdala, Ventromedial Hypothalamus and Periaqueductal Gray on Fear-Potentiated Startle

(2008) Zuowei Zhao et al.   NEUROPSYCHOPHARMACOLOGY

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

(2008) D. T. George et al.   SCIENCE

[3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain

(2006) Cristiana Griffante et al.   BRITISH JOURNAL OF PHARMACOLOGY